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Abstract
The goal of the innate immune system is containment of a pathogen at the site of infection prior to the initiation of an
effective adaptive immune response. However, effector mechanisms must be kept in check to combat the pathogen while
simultaneously limiting undesirable destruction of tissue resulting from these actions. Here we demonstrate that innate
immune effector cells contain a peripheral poxvirus infection, preventing systemic spread of the virus. These innate immune
effector cells are comprised primarily of CD11b+Ly6C+Ly6G- monocytes that accumulate initially at the site of infection, and
are then supplemented and eventually replaced by CD11b+Ly6C+Ly6G+ cells. The phenotype of the CD11b+Ly6C+Ly6G+ cells
resembles neutrophils, but the infiltration of neutrophils typically occurs prior to, rather than following, accumulation of
monocytes. Indeed, it appears that the CD11b+Ly6C+Ly6G+ cells that infiltrated the site of VACV infection in the ear are
phenotypically distinct from the classical description of both neutrophils and monocyte/macrophages. We found that
CD11b+Ly6C+Ly6G+ cells produce Type I interferons and large quantities of reactive oxygen species. We also observed that
depletion of Ly6G+ cells results in a dramatic increase in tissue damage at the site of infection. Tissue damage is also
increased in the absence of reactive oxygen species, although reactive oxygen species are typically thought to be damaging
to tissue rather than protective. These data indicate the existence of a specialized population of CD11b+Ly6C+Ly6G+ cells
that infiltrates a site of virus infection late and protects the infected tissue from immune-mediated damage via production
of reactive oxygen species. Regulation of the action of this population of cells may provide an intervention to prevent
innate immune-mediated tissue destruction.
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Introduction
Typically, the acute innate immune response to a peripheral
challenge involves rapid infiltration of Ly6C+Ly6G+ neutrophils,
followed by Ly6C+Ly6G- monocytes, in a process that involves
chemoattraction mediated by arachidonic acid metabolites,
cytokines, and chemokines [1]. Both neutrophils and monocytes
mediate inflammation, but monocytes are also thought to play a
major role in clearance of apoptotic neutrophils and restoration of
tissue homeostasis [2,3]. Neutrophils and monocytes are not,
however, homogeneous populations of cells, and subtypes of these
cells have been described based on their expression of surface
markers or production of cytokines. A full understanding of the
phenotype and function of each of these cell populations is
required in order to understand (and manipulate) the mechanisms
that clear pathogens, prevent systemic spread, and prevent or
reduce immune–mediated tissue damage at the site of infection.
The majority of studies investigating the role of innate immune
effector cells have been conducted using either sterile inflamma-
tion models or bacterial infections. Here we have examined the
role of innate immune effector cells in protection against
peripheral infection with virus. Many investigations studying
antiviral immunity have utilized systemic routes of infection
(intraperitoneal or intravenous) or examined infections in the
respiratory tract. However, numerous viral infections are trans-
mitted through breaks in the skin, and the dermal route of
inoculation is favored for delivery of viral vaccine vectors [4,5,6].
Following infection of the skin with a pathogenic virus, replication
occurs locally unless controlled by the innate immune system, and
subsequently the virus spreads systemically to cause disease. After
intradermal infection with vaccinia virus (VACV), a natural
peripheral route of infection [7], the immune system prevents
systemic spread of the virus [8]. A large number of the infiltrating
cells at the site of infection are F4/80+, likely representing
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monocytes/macrophages [9,10]. Although CD4+ T cells and
antibodies have been implicated in the control of VACV infection
following systemic challenge [11], the cells responsible for
preventing systemic spread of VACV following an intradermal
infection have not been identified.
Several recent studies have described important roles for
monocytic cells in the immune responses to various intracellular
pathogens [12,13], including viruses [14,15,16]. In respiratory
infection, depletion of alveolar macrophages enhances the spread
of VACV to peripheral sites such as the ovaries, indicating that
these cells may play an important role in anti-VACV immunity
[17]. Following systemic infection with VACV, TLR2-mediated
recognition of uncharacterized viral components causes both IL-6
production [18] and Type I interferon production by
Ly6C+CD11b+ cells [19], resulting in a reduction in virus titers.
However, the role of these innate immune effector cells and
molecules in control of virus spread from a natural peripheral site
of infection as well as their role in tissue regeneration following
infection, has not been addressed. In addition, the role of
Ly6C+Ly6G+ cells in protective immunity and tissue protective
responses following VACV infection is unknown.
Here we describe the role of Ly6C+Ly6G- monocytes in
preventing systemic spread of virus from a dermal site of infection
without a requirement for T cell infiltration. In addition, we
describe the role of Ly6C+Ly6G+ cells that infiltrate the site of
infection subsequent to the accumulation of monocytes. These
Ly6C+Ly6G+ cells produced Type I interferon and mediated tissue
repair via the production of reactive oxygen species. These
findings demonstrate the complexity of the cellular innate response
to peripheral virus infections, and how the response differs from
innate responses to a sterile inflammatory stimulus. Thus, our
results demonstrate the plasticity of innate immune effector
compartments, describe a previously unknown role for a subset
of Ly6C+Ly6G+ cells, and show that reactive oxygen species
(ROS) production by these cells allows the resolution, rather than
the exacerbation, of tissue damage during an acute infection.
Results
Phagocytes prevent the systemic spread of VACV
following peripheral infection
To gain insight into the mechanisms deployed by the immune
system to prevent the systemic spread of virus following a
peripheral infection, we infected mice in the ear with VACV
and monitored both virus replication and the infiltration of
populations of immune effector cells to the ear at various times
post infection. Virus replicated exponentially in the ear pinnae
until day 5, at which point the titer began to plateau (Fig. 1A).
Virus titers then dropped until virus was finally cleared when the
scab that formed at the site of infection fell off between day 12 and
15 post infection. At day 5 post infection, the time point at which
virus replication plateaus, no significant accumulation of ab TCR
T cells was observed at the site of infection (Fig. 1B). However,
the plateau of virus replication coincided with the peak in numbers
of CD11b+ cells (Fig. 1B). The CD11b+ population contained a
small but reproducible number of CD11clo cells that expressed
CD11b, but not B220 (CD45RA), and likely represent monocyte-
derived DC (Fig. S1). We did not observe infiltration of CD11c+
B220+ plasmacytoid DC, proposed to be the primary producer of
Type I IFN, to the site of infection up to day 11 post infection
(data not shown).
To determine the role of the infiltrating CD11b+ cells, we
intravenously injected clodronate liposomes to induce apoptosis of
the phagocytic cells that internalize the liposomes [20]. We
typically observed a 70–80% depletion of CD11b+ cells at the site
of infection throughout the time course of the experiment upon
repeated injection of clodronate liposomes (data not shown).
Liposome injection resulted in a minor increase in VACV titers in
the ear pinnae of the phagocyte-depleted mice on days 5–9 as
compared to control mice (Fig. 1C). VACV replication is
completely confined to the ear pinnae following intradermal
infection with a dose of 104 pfu [8]. The confinement of virus
replication to the ear pinnae contrasts with systemic routes of
infection, such as intraperitoneally or intravenously, after which
virus can be found in multiple organs and tissues, including the
ovaries, the primary site of VACV replication in a female mouse.
Because the spread of VACV to the ovaries is accelerated
following the depletion of alveolar macrophages after an intranasal
challenge [17], we examined the role of phagocytes in the
confinement of viral replication to the ear pinnae. The presence of
replicative VACV in the ovaries was analyzed using a plaque assay
following depletion with clodronate liposomes. Replicative VACV
was observed in the ovaries of mice undergoing clodronate
liposome treatment, but not in control mice (Fig. 1D). VACV was
detected in the ovaries beginning on day 5 and peaked on day 7 at
a level 1000-fold in excess of the original inoculum. Notably,
depletion of T cells systemically and in the ear using an anti-Thy1
antibody did not increase virus titers in the ear through day 9 post
infection (Fig. S2) or allow detection of VACV in the ovaries (data
not shown). Therefore phagocytes, but not T cells, play a vital role
in controlling virus replication at the site of infection and in
preventing the systemic spread of VACV following a peripheral
infection.
CD11b is a broadly expressed integrin subunit that is found on
neutrophils, monocytes, macrophages and some DC subsets. In an
attempt to specifically address the role of monocyte/macrophages
in control of virus replication at the site of infection and the spread
of VACV systemically, we utilized Macrophage Fas-Induced
Apoptosis (MAFIA) mice which encode both a suicide gene and
Green Fluorescent Protein (GFP) driven by the c-fms (CD115/
MCSF receptor) promoter [21]. Injection of the drug AP20187
leads to dimerization of the suicide protein, activation of the Fas
pathway, and subsequent apoptosis of cells expressing CD115.
Previous publications have shown that monocyte/macrophages in
MAFIA mice are GFP+ and are depleted upon AP20187
treatment, whereas neutrophils express very little GFP and are
unaffected by AP20187 treatment in these mice [21]. In our
studies, repeated injections of AP20187 produced .80% depletion
Author Summary
During a natural virus infection, small doses of infectious
virus are deposited at a peripheral infection site, and then
a ‘‘race’’ ensues, in which the replicating virus attempts to
‘‘outpace’’ the responding immune system of the host. In
the early phases of infection, the innate immune system
must contain the infection prior to the development of an
effective adaptive response. Here we have characterized
the cells of the innate immune system that move to a site
of peripheral virus infection, and we find that a subset of
these cells display atypical expression of cell surface
molecules, timing of infiltration, and function. These cells
protect the infected tissue from damage by producing
reactive oxygen molecules, which are widely accepted to
increase tissue damage. Therefore our findings indicate
that during a peripheral virus infection, the typical rules
governing the function of the innate immune system are
altered to prevent tissue damage.
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of CD11b+ cells at the site of infection (data not shown). Similar to
clodronate liposome treatment, AP20187 treatment of MAFIA
mice produced a minor but reproducible increase in VACV titers
in the ear of infected mice (Fig. 1E). AP20187 administration to
MAFIA mice also allowed systemic spread of virus in the majority
of mice (Fig. 1F), but the VACV titers found in the ovaries of
Figure 1. Phagocytic cells control the systemic spread of virus from the ear pinnae and tissue damage at the site of infection. Wild-
type (A–D, G, H) or MAFIA (E, F, G, H) mice were infected i.d. in the ear pinnae with VACV. Ear pinnae or ovaries were harvested at various days post-
infection. Ear (A, C, E) or ovary (D, F) lysates were used in a plaque assay to determine viral replication kinetics in vivo. B) Immune cells were isolated
from infected ear pinnae and identified as either T cells (open circles; TCRb+, CD90+) or phagocytes (filled squares; CD11b+, CD90-, NK1.1-, CD19-)
using flow cytometry. Infected ear pinnae (C, E) and ovaries (D, F) were harvested from clodronate liposome-(C, D; filled circles) or vehicle-(C, D; open
squares) treated wild-type mice and AP20187-(E, F; filled circles) or vehicle-(E, F; open squares) treated MAFIA mice. G, H) The tissue damage in wild-
type mice treated with clodronate liposomes (filled squares) or vehicle (filled circles), or MAFIA mice treated with AP20187 (open squares) was
documented on indicated days post infection, by measuring lesion size (G) or loss of tissue (H). Data is representative of at least three independent
experiments and data shown represent mean cell numbers or virus titers +/- SEM from four ears at each time point and mean lesion size or tissue
damage +/- SEM from 10 ears mice at each time point are depicted in (G, H).
doi:10.1371/journal.ppat.1002374.g001
The Myeloid Response to Peripheral Virus Infection
PLoS Pathogens | www.plospathogens.org 3 November 2011 | Volume 7 | Issue 11 | e1002374
treated MAFIA mice were 105-fold lower than titers seen following
clodronate liposome treatment (Fig. 1D). These data indicated
that the primary cell type required for preventing systemic spread
of VACV is a subset of phagocytic cells that was depleted
effectively in mice treated with clodronate liposomes, but less
effectively depleted in MAFIA mice treated with AP20187.
VACV infection in the ear causes significant pathology that can
be quantified by measurement of swelling, lesion size and tissue
damage [8]. The pathology we observed following VACV
infection differed slightly from published reports, a finding that
is likely caused by differing sources of laboratory animals and
different housing conditions between institutions. When we
depleted mice of phagocytes using either clodronate or AP20187
treatment, the pathology at the site of VACV infection was
dramatically increased at late times. To quantify this pathology,
we measured the lesion size and tissue damage, which represents
the loss of necrotic tissue from the ear [8], in infected mice that
were untreated or depleted using clodronate liposomes or
AP20187 . Both lesion size and tissue loss was significantly greater
in mice depleted of phagocytes using either methodology (Fig. 1G,
H). Notably, both the increase in lesion size and the tissue loss in
phagocyte-depleted mice occurred primarily at time points after
the minor increase in virus replication had been controlled. These
data indicate a dual role for phagocytes during VACV infection,
namely blockade of systemic spread and reduction of host-
mediated tissue pathology.
Distinct monocyte populations migrate to the site of
VACV infection
In order to investigate which cell population was required to
prevent spread of VACV from the site of infection, we needed to
further characterize the phenotypes of cells within the infiltrating
CD11b+ population at the site of infection. We examined
infiltration of CD11b+ cells to the ear of MAFIA mice at various
times post infection, taking care to ensure that the cells that we
observed were not doublets (which could confound their identity)
as outlined in our gating strategy (Fig. S3). Virtually all of the
CD11b+ cells infiltrating the site of infection were GFP+ in MAFIA
mice (Fig. 2A), until day 7 post infection when a CD11b+ GFP-
population began to accumulate [9]. Thus, either all CD11b+ cells
infiltrating the site of infection were of monocytic origin or the use
of a VACV infection model led to expression of GFP within cells
in MAFIA mice that were not of monocytic origin. Therefore it
was necessary to distinguish monocyte/macrophages from neu-
trophils, which comprise another likely major population of
infiltrating phagocytes.
There are few phenotypic markers that can distinguish
neutrophil and monocytes/macrophage populations. One of these
markers is CD115, but we were unable to detect infiltrating
CD11b+GFP+CD115+ cells at the site of VACV infection (data not
shown) although similar digestion protocols in different tissues in
uninfected mice did produce CD115 staining. As surrogate GFP
expression driven by the CD115 promoter did not distinguish
between these cells types (Fig. 2A), we examined expression of cell
surface Ly6C and Ly6G, as published work indicates that Ly6C is
expressed by monocytes [22,23], whereas both Ly6C and Ly6G
are expressed by granulocytes [24,25]. Using antibodies specific
for Ly6C and Ly6G to analyze the CD11b+ cell infiltrate by flow
cytometry, we observed several different cell populations accumu-
lating in the ear over the course of the infection (Fig. 2B). The
accumulation of immune cell populations, including Ly6C+Ly6G+
neutrophils, did not occur until day 2–3 post infection (Fig. 2A–
B).
A population of Ly6C+Ly6G- monocytes was detected in the ear
at numbers above uninfected tissue on day 3 post infection and
represented the predominant CD11b+ cell at the site of infection
through day 7 (Fig. 2B). Small numbers of Ly6C+Ly6G+ cells could
be identified in the ear at early times after infection, but the numbers
of these cells increased significantly after 5 days of infection and
became the major population beyond day 7. Typically, this
Ly6C+Ly6G+ population would be classified as neutrophils.
However, the timing of infiltration of these Ly6C+Ly6G+ cells is
not consistent with the infiltration of neutrophils that infiltrate a site
of insult early, before monocytes, and die rapidly unless replaced
[2]. Similar populations of infiltrating Ly6C+Ly6G+ cells were
observed at the site of infection 5 days after dermal infection with
other viruses (Fig. S4), indicating that the later infiltration of
Ly6C+Ly6G+ cells is not specific to VACV infection. Closer analysis
revealed that the Ly6C+Ly6G+ cells expressed several proteins
considered to be monocyte/macrophage markers, including CD68,
F4/80, CD200 and the scavenger receptor CD163 (Fig. 2C–F).
To investigate whether the Ly6C+Ly6G+ cells that we observed
were monocytes, we infected CX3CR1
+/GFP mice in which one of
the copies of the CX3CR1 chemokine receptor has been replaced
by GFP [26]. All monocytes in these mice express GFP at high
levels [26]. Following VACV infection, the CD11b+Ly6C+Ly6G-
cells in the ear pinnae expressed GFP (Fig. 2G). However, the
CD11b+Ly6C+Ly6G+ cells did not express GFP driven by the
CX3CR1 promoter, indicating that they are unlikely to be derived
from the monocyte population (Fig. 2G). To further investigate
the phenotype of infiltrating cell populations from the ear of
VACV infected mice, we isolated Ly6G+ and Ly6G- cells from ear
pinnae 5 days post-infection by magnetic separation and visualized
their nuclear morphology by microscopy. Both Ly6G- and Ly6G+
fractions were comprised primarily of mononuclear cells (Fig. 2H).
Therefore it appears that the Ly6C+Ly6G+ cells that infiltrated the
site of VACV infection in the ear are phenotypically distinct from
the classical description of both neutrophils and monocyte/
macrophages.
To identify whether Ly6C+Ly6G+ cells migrate to the site of
infection or expand in situ, we blocked infiltration of these cells to
the infection site with a non-depleting antibody targeting the
integrin subunit CD11b. Anti-CD11b antibody treatment reduced
infiltration of both Ly6C+Ly6G- and Ly6C+Ly6G+ cells equally
(Fig. 3A), indicating a similar requirement for transport across the
endothelial cell layer for each of these cell populations. To study
whether the Ly6C+Ly6G+ cell population we observed at the site
of VACV infection is derived from the circulation, we injected
fluorescent fluorospheres i.v. and examined the migration of cells
that had ingested the fluorospheres to the site of VACV infection.
Prior to fluorosphere injection, we depleted circulating monocytes
with clodronate to ensure that we labeled cells that were mobilized
from the bone marrow [27]. Similar profiles of Ly6C+Ly6G+ and
Ly6C+Ly6G- cells in the ear contained fluorospheres after
internalization in the blood (Fig. 3B), suggesting that both
populations repopulate the circulation following clodronate
depletion of monocytes. Taken together, these data indicate that
neither population of cells is likely to be derived from resident cells,
but rather each moves into the site of infection from the blood.
Function of the monocyte/macrophage subpopulations
The true measure of cellular specialization is best demonstrated
by the dedicated function of a cell type. Thus, we analyzed the
Ly6C+Ly6G+ and Ly6C+Ly6G- populations for differences in
function. The Ly6C+Ly6G- population at the site of infection
expressed inducible nitric oxide synthase (iNOS) and, when
exposed to CpG oligonucleotides, a portion of these Ly6C+Ly6G-
The Myeloid Response to Peripheral Virus Infection
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cells produced TNF-a (Fig. 4A, B). In contrast, none of the
Ly6C+Ly6G+ cells expressed iNOS above the level of CD11b-
cells, nor did the Ly6C+Ly6G+ cells produce TNF-a either directly
ex vivo or following stimulation with CpG oligonucleotides.
Although both TNF-a [28] and iNOS [29,30] have been reported
to be required for efficient control of VACV replication in mice,
we did not observe any difference in VACV replication in mice
lacking iNOS compared to wild-type mice (Fig. S5). Production of
Type I interferons is also essential to control VACV replication in
vivo [31,32] so we examined production of IFN-a and IFN-b by
Ly6C+Ly6G- and Ly6C+Ly6G+ cells at the site of VACV
infection. We found that Ly6C+Ly6G+ cells produced significant
levels of Type I IFN when compared to either CD11b- cells or
Ly6C+Ly6G- cells when directly isolated from the site of VACV
infection (Fig. 4C, D). Notably, this production of Type I IFN
occurred without the need for any additional stimulation.
Ly6C+Ly6G+ neutrophils typically produce large quantities of
ROS, so we incubated cells isolated from VACV-infected ears
with a dye that becomes fluorescent upon exposure to ROS (CM-
H2DCFDA). Ly6C
+Ly6G- cells stained with the ROS substrate at
a higher level than CD11b- cells, but Ly6C+Ly6G+ cells produced
much higher levels of ROS (up to a 2 log10 shift in fluorescence)
without additional stimulation (Fig. 4E). These data indicate that
the Ly6C+Ly6G- and Ly6C+Ly6G+ cells are functionally distinct,
and demonstrate that both cell types provide functions important
in the control of VACV replication.
Figure 2. Ly6C+Ly6G- and Ly6C+Ly6G+ subpopulations of cells at the site of VACV infection.MAFIA (A–F), CX3CR1+/GFP (G) or wild-type (H)
mice were infected in the ear pinnae with VACV and the ears harvested at various days post infection (A, B) or on day 5 post infection (C–H). A) The
phagocyte population (CD11b+, CD90-, NK1.1-, CD19-) in the ear was analyzed (using a gating strategy outlined in Fig. S3) for expression of GFP
(driven by the CD115 promoter) and CD11b. B) The GFP+CD11b+ population from A) was analyzed for expression of Ly6C and Ly6G. C–G) The
resulting Ly6C+Ly6G- (open histograms, top row) and Ly6C+Ly6G+ (open histograms, bottom row) populations were analyzed for the expression of
various intracellular (C) or cell surface (D–F) markers using antibodies or GFP as a surrogate for CX3CR1 expression (G) and compared to CD11b- cells
(filled histogram). H) Cells from ear pinnae 5 days post-infection were magnetically sorted based on Ly6G expression, fixed onto slides using
cytofugation, and stained. Data shown are representative of at least three independent experiments in which three mice were examined at each time
point.
doi:10.1371/journal.ppat.1002374.g002
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Ly6G+ cells are tissue protective
To ascertain whether production of Type I IFN by Ly6-
C+Ly6G+ cells is required for efficient control of VACV
replication at the site of infection, we depleted Ly6G+ cells using
1A8 antibody specific for Ly6G. This antibody depletes Ly6G+
cells while leaving Ly6C+Ly6G- cells unaffected, in contrast to
antibodies used to deplete Gr1+ cells, such as RB6-8C5 [25]
(Fig. 5A). Mice receiving the anti-Ly6G 1A8 antibody displayed a
modest 2.5-fold increase in virus replication in the ear pinnae on
days 5 and 7 post-infection (Fig. 5B) comparable to that observed
Figure 3. Both Ly6C+Ly6G- and Ly6C+Ly6G+ subpopulations extravasate into the site of infection. A) Mice were treated i.v. with either
non-depleting anti-CD11b (filled circles) or isotype control (open squares) and infected i.d. in the ear pinnae with VACV. Ear pinnae were harvested at
various times post-infection and the phagocyte population was then analyzed for the Ly6C+Ly6G- (top) and Ly6C+Ly6G+ (bottom) subpopulations. B)
Mice either untreated (left) or treated once (as opposed to the repeated treatment in Fig. 1) with clodronate liposomes (right) were injected with
fluorospheres and then infected i.d. with WR VACV. After 5 days of infection, ear pinnae were harvested and Ly6C+Ly6G- (top) and Ly6C+Ly6G+
(bottom) phagocytes were analyzed for fluorosphere uptake using flow cytometry. Data are representative of at least three independent experiments
and mean phagocyte numbers +/- SEM from four ears at each time point are depicted in A).* represents p,0.05 using a Student’s T-test.
doi:10.1371/journal.ppat.1002374.g003
Figure 4. Ly6C+Ly6G- and Ly6C+Ly6G+ cells have distinct functional profiles. Mice were infected i.d. in the ear pinnae with VACV. Ear pinnae
were harvested at 5 days post-infection. The Ly6C+Ly6G- (top, open histograms) and Ly6C+Ly6G+ (bottom, open histograms) CD11b+ monocyte
subpopulations were analyzed for the expression of various cytokines/effector molecules using antibodies (A-D) or a reactive dye triggered by
exposure to ROS (E) and compared to CD11b- cells (filled histograms). For TNF-a staining, cells were first incubated with CpG DNA. Data are
representative of at least three independent experiments in which the phenotype of at least two mice were examined independently.
doi:10.1371/journal.ppat.1002374.g004
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following clodronate liposome treatment or MAFIA-dependent
depletion. In contrast to treatments that globally deplete
monocyte/macrophages, such as clodronate treatment, adminis-
tration of the 1A8 antibody resulted in undetectable levels of
replicative VACV in the ovaries (data not shown). Virus
replication in the ear was controlled by day 9 post-infection.
Therefore, Ly6G+ cells, including the population of Ly6C+Ly6G+
cells we observed at the site of infection, likely play only a minor
role in reducing virus replication and spread.
When we depleted mice of Ly6G+ cells, the pathology at the site
of VACV infection was dramatically increased and large areas of
infected ears became necrotic and eventually fell off (Fig. 5C). To
quantify this pathology, we measured the lesion size and tissue
damage, which represents the loss of necrotic tissue from the ear
[8], in infected mice that were vehicle treated or depleted of
Ly6G+ cells. Both lesion size and tissue loss was significantly
greater in mice depleted of Ly6G+ cells (Fig. 5D, E) than in those
treated with isotype control antibody (Fig. S6). Notably, both the
increase in lesion size and the tissue loss in anti-Ly6G antibody-
treated mice occurred primarily at time points after the minor
increase in virus replication had been controlled. To ensure that
the tissue protective function of Ly6G+ cells occurred after the
control of VACV replication we injected anti-Ly6G antibody or
isotype control on day 10 post-infection and monitored lesion size
(not shown) and tissue damage (Fig. 5F). As above, depletion of
Ly6G+ cells following control of virus replication enhanced tissue
damage. These data indicate a tissue protective role for Ly6G+
cells during VACV infection.
Tissue protection is mediated by ROS
Because production of ROS is the major functional phenotype
of Ly6C+Ly6G+ cells following VACV infection, we investigated
the role of ROS production in control of virus replication in the
ear, control of virus spread to the ovaries, and tissue protection.
We infected gp91-/- mice that lack the membrane component of
the phagocyte NADPH oxidase, and therefore cannot generate
ROS [33]. Gp91-/- mice displayed slightly (0.5-fold) enhanced
replication of VACV in the ear at day 5 post-infection (Fig. 6A)
and, similar to wild-type mice, no replicating virus could be
detected in the ovaries (data not shown). However, the ears of
gp91-/- mice displayed very similar characteristics upon infection
to those of mice depleted of Ly6G+ cells, namely that large
portions of the ear became necrotic and were eventually shed
(Fig. 6B). When we quantified lesion size and tissue loss as
outlined above, we observed that a lack of ROS significantly
increased tissue damage at time points when there was no effect
upon virus replication (Fig. 6C-D). There was no significant
difference between the infiltration of CD11b+ or Ly6C+Ly6G+
cells between wild-type and gp91-/- mice, indicating that a
difference in chemotaxis of tissue protective cells did not account
for the difference in tissue damage observed in gp91-/- mice (Fig.
S7). In addition, depletion of Ly6G+ cells in gp91-/- mice did not
exacerbate or ameliorate tissue damage (Fig. S8) in contrast to
wild-type mice, where treatment with anti-Ly6G dramatically
increased tissue damage (Fig. 5 D, E). These data demonstrate
that production of ROS, likely by Ly6C+Ly6G+ cells, prevents
tissue damage following VACV infection.
The mechanisms responsible for the pathology observed at the
site of VACV infection remain unknown, but a great deal of recent
work has focused on the ability of myeloid cell population to
suppress T cell activity. Therefore we examine the ability of T cells
to induce tissue damage in mice lacking ROS. We depleted T cells
with anti-Thy1 antibody (Fig. S2) and measured lesion size and
tissue damage as above. If T cells were responsible for tissue
damage and their function was modulated by ROS we would
expect to observe a reduction in the tissue damage in gp91-/-
depleted of T cells. We did not observe a decrease in lesion size
(Fig. 6E) or tissue damage (Fig. 6F) in mice treated with anti-
Thy1 antibody, and in some, but not all, experiments we observed
an increase in damage in T cell depleted mice. Therefore ROS-
mediated modulation of tissue damage is not achieved via an effect
on T cell activity.
Discussion
In this study, we describe two populations of innate immune
effectors, identified as CD11b+Ly6C+Ly6G- and CD11b+Ly6-
C+Ly6G+ that migrate to a peripheral site of virus infection. These
populations are phenotypically distinct, and mediate multiple
functions that control virus replication, prevent systemic spread of
virus, and simultaneously reduce tissue damage. We demonstrate
the recruitment of a non-typical Ly6C+Ly6G+ population that
appears to mediate both effector (Type I interferon production)
and immunomodulatory (reduction of tissue damage) functions
following virus infection. Depletion of this population of cells
reveals that their function is vital in protection of tissue from
catastrophic damage mediated by the inflammatory response.
Manipulation of their function may allow the generation of tissue
protective responses during infection to prevent immune-mediated
pathology.
Our observation that Ly6C+Ly6G+ cells produce Type I
interferons is in contrast to previous publications in which
production of antiviral Type I IFN by innate immune effectors
is typically held to be the role of plasmacytoid DC [34]. We did
not observe CD11c+B220+ plasmacytoid DC at the site of
infection, and we were unable to attribute an effector function
such as cytokine or other inflammatory mediator production to the
small number of CD11c+ cells with the phenotype of monocyte-
derived DC at the site of infection. These ‘‘inflammatory DC’’
may play a role in antigen presentation to CD4+ T cells that
migrate to the site of infection at later time points [35]. Following
systemic VACV infection, TLR2-mediated recognition by
CD11b+Ly6C+Ly6G-, but not Ly6C+Ly6G+, cells leads to the
production of Type I IFN [19]. This apparent discrepancy could
be explained by the ability of systemically administered VACV to
reach lymphoid resident macrophage populations that have a
differential ability to produce Type I interferon. The natural route
of infection with VACV appears to be via touch [36], and dermal
infection reveals a role for immune evasion molecules that other
routes of infection do not [7]. If natural infection is via the dermal
route, then only cells migrating to the site of infection may be
exposed to the virus, explaining the difference in cell type
producing Type I interferons in our study.
It is clear from our data that Ly6C+Ly6G+ cells are required to
modulate the immune response and reduce tissue damage
following infection with VACV. The enhanced damage observed
following depletion of Ly6G+ cells is unlikely to result from the
minor increases in VACV titers in the ear. A two-fold increase in
virus titer is minor, as each infected cell will produce 102–103
progeny virions, so major changes in control of virus replication
would likely produce log10 changes in titer. We show that
Ly6C+Ly6G+ cells are present after clearance of virus, presumably
to aid in recovery of the tissue from immune-mediated pathology.
Modulation of tissue damage requires the production of ROS,
which are often associated with tissue damage. Oxygenation is
often required for tissue repair, however, and the presence of
oxygen may allow greater production of oxygen radical that are
required for tissue repair, or modulation of the immune response
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to reduce tissue damage [37,38]. The production of ROS can
modulate both T cell responses and innate immune responses
[39,40,41,42]. Our data indicate that T cell depletion in gp91-/-
mice does not reduce the lesion size or tissue damage following
VACV infection, suggesting that production of ROS by
Ly6C+Ly6G+ cells modulates tissue damage in a T cell-
independent manner. The exact mechanisms responsible for the
profound damage found in the ear of mice infected with VACV
Figure 5. Depletion of Ly6G+ cells leads to increased tissue damage at the site of VACV infection. Mice were treated with vehicle (A-left,
B, D, E - open squares), isotype control antibody (F-open squares) or anti-Ly6G antibody (A-right, B, D, E, F - filled circles) and infected i.d. in the ear
pinnae with VACV. A) The presence of Ly6C+Ly6G- and Ly6C+Ly6G+ monocytes populations in the ear pinnae was measured 5 days post-infection. B)
Replicating virus titers were measured at various times post infection. C-F) The tissue damage in mice treated with anti-Ly6G antibody for the entire
course of infection (C, D, E) or after day 10 post infection (F, arrowed) was documented visually on indicated days post infection (C), by measuring
lesion size (D) or loss of tissue (E, F). Data are representative of at least three independent experiments. Mean virus titers +/- SEM from four ears at
each time point are depicted in (B). Mean lesion size or tissue damage +/- SEM from five mice at each time point are depicted in (D, E). * represents
p,0.05 using a Student’s T-test.
doi:10.1371/journal.ppat.1002374.g005
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remains unknown, and is a focus of our ongoing studies. The late
time point at which damage occurs may reflect a role for antibody-
mediated mechanisms that act through innate effector cells to
initiate damage. Ly6C+Ly6G+ cells express several other molecules
capable of suppressing immune responses, including CD163 and
CD200. CD200-mediated suppression targets any cell expressing
CD200R, including monocytes, macrophages, granulocytes, and
T cells [43]. The activity of CD163, a scavenger receptor involved
in the clearance of hemoglobin, leads to the up-regulation of the
enzyme HO-1 [44]. In turn, this enzyme is both anti-inflammatory
[45] and tissue-protective [46,47,48] through pathways involving
CO, bilirubin, and Fe2+. In addition, ROS are critical mediators of
signaling by cytokine and hormone receptors that may be required
for tissue repair, such as insulin, platelet-derived growth factor,
fibroblast growth factor and angiotensin [49]. Thus, Ly6C+Ly6G+
cells possess many mechanisms capable of modulating the immune
response in order to provide tissue protection and repair.
The role of the Ly6C+Ly6G- monocyte population in immunity
to a peripheral virus infection is less defined, as there is currently
no method available to specifically deplete these cells without
affecting the Ly6C+Ly6G+ cells. Ly6C+Ly6G- monocyte recruit-
ment occurs prior to the recruitment of ab T cells and coincides
with the time point at which virus replication is controlled. By
subtractive reasoning we are able to gain an insight into the role of
these cells. The Ly6C+Ly6G- monocyte population may be
required for control of virus replication at the site of infection,
but systemic depletion of populations including these cells does not
substantially increase virus titers in the ear. Clearly cells that are
depleted by treatment with clodronate liposomes do prevent
systemic spread of the virus via an unknown mechanism that does
Figure 6. Loss of NADPH-oxidase activity leads to increased tissue damage at the site of VACV infection. A–D) Wild-type (open squares)
or GP91-/- (filled circles) mice were infected i.d. in the ear pinnae with VACV. A) Replicating virus titers in the ear pinnae were measured at various
times post infection. The tissue damage in GP91-/- mice was documented visually on day 9 (B), or by measuring lesion size (C) or loss of tissue (D) at
various times post infection. E, F) GP91-/- mice were treated with anti-Thy1 (closed circles) or isotype control (open squares) and lesion size (E) and
tissue damage (F) quantified at the days shown. Mean virus titers +/- SEM from four ears mice at each time point are depicted in (A). Mean lesion size
or tissue damage +/- SEM from ten ears at each time point are depicted in (C, D, E F). * represents p,0.05 using a Student’s T-test.
doi:10.1371/journal.ppat.1002374.g006
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not involve iNOS. Subcapsular sinus macrophages have been
proposed as a gatekeeper cell type that prevents systemic spread of
viruses [50,51] and these cells are known to be infected following
VACV infection [52]. However we observed no depletion of
subcapsular sinus macrophages following systemic depletion with
clodronate liposomes, ruling out these cells as the ones responsible
for controlling systemic spread of VACV following intradermal
infection. It is possible that clodronate-mediated depletion of
Ly6C+Ly6G- monocytes (or other cells) at sites other than the ear
pinnae or subcapsular sinus is responsible for allowing systemic
spread of VACV following peripheral infection, but we have been
unable to identify specific populations of cells that are depleted by
systemic administration of clodronate and definitely prevent virus
spread.
The derivation of the Ly6C+Ly6G+ cell population we have
described remains unknown. Ly6C+Ly6G+ cells are recruited from
the blood at a time point after infection that is not normally
associated with neutrophil recruitment. Ly6C+Ly6G+ cells have
CD115 promoter activity at some point during their differentiation
and display a mononuclear morphology but do not express the
monocyte marker CX3CR1. The latter observation could be
related to infection with VACV, as this virus expresses an immune
modulator that causes the production of glucocorticoids [53], and
in vivo administration of glucocorticoids can induce production of
a monocytic cell type that downregulates expression of CX3CR1
[54]. These glucocorticoid-induced cells express many of the
surface markers of myeloid derived suppressor cells (MDSC), a
heterogeneous cell population described as suppressors of T cell
responses in a tumor microenvironment [55,56]. The Ly6-
C+Ly6G+ cells found at the site of VACV infection share
expression of many surface markers with granulocytic MDSC,
and produce large quantities of ROS, which MDSC use to
modulate T cell activity [57,58,59]. However, MDSC are typically
identified by expression of CD1b and Gr-1, a phenotype shared
with neutrophils and inflammatory macrophages, and a full
pathway of differentiation of these cells during resting or
pathological conditions is yet to be published. The Ly6C+Ly6G+
cells we describe in this study share expression of some surface
markers and some functions with neutrophil and monocyte
populations, as well with MDSC. Without the definition of a
widely agreed upon panel of markers that identify MDSC it is
therefore impossible to conclude that the Ly6C+Ly6G+ cells are
MDSC. Indeed, in the absence of definitive evidence that the
Ly6C+Ly6G+ cells derive from a discrete lineage, their immuno-
modulatory function thus appears insufficient at this time to define
the existence of a novel cell population.
In summary, we have identified and described the role of a
distinct population of Ly6C+Ly6G+ cells that adds to the
complexity of the phagocyte compartment [60]. These Ly6-
C+Ly6G+ cells are innate immune cells that regulate the
destructive action of the innate immune system, reducing tissue
damage and allowing wound healing. Modulation of the activity of
these cells presents an attractive therapeutic strategy for preventing
tissue damage in a wide range of infections and other pathologies.
Materials and Methods
Mice
All mice were housed in the specific pathogen free animal
facility of the Hershey Medical Center. C57BL/6 mice were
purchased from Charles River Laboratories (National Cancer
Institute, Frederick, MD). iNOS-/- mice [61] were purchased from
Taconic. Gp91-/- mice [33] and MAFIA mice [21] were
purchased from Jackson Laboratory. All transgenic or knockout
mouse strains were on the C57BL/6 background after a minimum
of 12 backcrosses to this strain. Mouse strains, with the exception
of C57BL/6, were subsequently bred at the Hershey Medical
Center. All animals were maintained in microisolator cages and
treated in accordance with the National Institutes of Health and
American Association of Laboratory Animal Care (AAALAC
International) regulations. All animal-related experiments and
procedures were approved by the Penn State Hershey Institutional
Animal Care and Use Committee.
Virus
Mice were injected in each ear pinna with 104 pfu VACV strain
Western Reserve in a volume of 10 ml [8]. To analyze the presence
of replicating virus, the ear pinnae or ovaries were harvested,
subjected to three freeze/thaw cycles, homogenized and sonicated.
Lysate was then placed on a monolayer of 143B cells, and a plaque
assay was used to determine viral titer [8].
Cell depletion
To deplete phagocytes, 200 ml of clodronate liposomes in PBS
were injected i.v. on days 0, 1, 3, and 4 of infection [20]. This
injection scheme effectively depletes monocytes and many
macrophage populations [27,62]. Cl2MDP (or clodronate) was a
gift of Roche Diagnostics GmbH, Mannheim, Germany. Lipo-
somes were prepared using Phosphatidylcholine (LIPOID E PC,
Lipoid GmbH) and cholesterol (Sigma). Depletion of GFP+ cells in
MAFIA mice was accomplished using AP20187 (Ariad Pharma-
ceuticals), as previously described [21]. AP20187 was diluted to a
working concentration of 0.55 mg/ml in sterile water containing
4% ethanol, 10% PEG-400, and 1.7% Tween immediately before
injection. AP20187 (10mg/kg) was injected i.v. daily for 5 days.
Depletion was maintained with injections AP20187 (1mg/kg)
every 3 days. Antibody-mediated depletion of Ly6G+ cells was by
injection of 0.5 mg of anti-Ly6G (1A8, BioXCell) i.p. every 4 days
[25].
5C6 (Anti-CD11b)-mediated blocking of phagocyte
extravasation
Monocyte extravasation was partially blocked using the anti-
CD11b antibody clone 5C6 [63]. Mice were injected i.v. with
0.5 mg/mouse of 5C6 antibody or an isotype control (rat IgG2b)
every 24 hours. The clone 5C6 recognizes a epitope distinct from
the anti-CD11b antibody clone M1/70 [63], so there is no 5C6-
mediated interference in the detection of CD11b+ cells by flow
cytometry.
Analysis of the immune cell infiltrate
Immune cells were isolated as previously described [9,10].
Briefly, ear pinnae were microdissected to increase surface area
and incubated in 1 mg/ml collagenase XI (Sigma) for 30 min at
37uC. The tissue was then passed through metal screens to create a
single cell suspension. RBC were lysed using ACK lysis buffer
(Invitrogen). Cells were then incubated in Fc Block (BD) and
stained in a solution of antibodies diluted in Fc Block and 10%
mouse serum (Sigma). To detect intracellular markers or cytokines,
cells were first fixed in 1% paraformaldehyde and stained and
washed in the presence of 0.5% saponin (Sigma). Antibodies were
from eBioscience unless noted otherwise and included anti-CD11b
(M1/70), -CD11c (N418), -CD19 (eBio1D3), -CD68 (FA-11), -
CD90 (53-2.1), -F4/80 (BM8), -IFN-a (RMMA-1), -IFN-b
(RMMB-1), -iNOS (6), -Ly6C (AL-21), -Ly6G (1A8), -NK1.1
(PK136), -TCRb (H57-597, BD Bioscience), -CD163 (ED2,
Serotec), and -TNF-a (MP6-XT22). Streptavidin (BD Bioscience)
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was used to label biotin-conjugated antibodies. For detection of
production of IFN-a, IFN-b and TNF-a, ex vivo cells were
incubated in the presence of 5 mg/ml brefeldin A (Sigma) for
4 hours prior to staining. To detect TNF-a production, cells were
incubated in the presence of 20 mg/ml CpG (Invivogen) for
2 hours prior to the addition of brefeldin A. For flow cytometry
analysis all sample acquisition was with a FACsCanto or LSRII
(BDBiosciences) in the Hershey Medical Center Flow Cytometry
Core Facility. Data were analyzed using FlowJo software
(Treestar) as outlined in Fig. S3.
Reactive oxygen detection
Cells isolated from infected ear pinnae, as described above, were
incubated in 20 mM CM-H2DCFDA in PBS for 30 min at 37uC
and developed for an addition 4–6 hours in the dark. Fluorescence
was detected by flow cytometry.
Monocyte tracking
Tracking of classical monocytes was accomplished using
fluorosphere labeling as previously described [27]. A 2.5% solids
solution of 0.5mm FITC-labeled latex beads (Polysciences, Inc) was
diluted 1:25 in sterile PBS. A 250 ml dose of this dilution was
injected i.v. alone or 1 day following an i.v. injection of 200 ml
clodronate liposomes. Phagocytes were then isolated from ear
pinnae, stained, and analyzed using flow cytometry as described
above.
Histology
Isolated cells were stained with a Phycoerythrin (PE)-conjugated
anti-Ly6G antibody (clone 1A8), then incubated with anti-PE
beads and separated using an AutoMACS sorter. The Ly6G+ and
Ly6G- fractions (which contained large amounts of debris that
were disregarded) were analyzed using Romanowsky staining.
Supporting Information
Figure S1 Infiltration of CD11c+ to the site of peripheral
VACV infection. Wild-type mice were infected with 104 pfu
VACV in the ear pinnae and ears were harvested at the days
shown. Cells were stained and analyzed as outlined in Fig. S3
below. CD11c+ cells represented a small fraction (around 15-20%)
of infiltrating CD11b+ cells and expression of CD11c did not
correlate with expression of other cellular markers (except CD11b)
or functional phenotypes.
(TIF)
Figure S2 Depletion of T cells does not lead to increased
viral titer. Wild-type mice were treated with either T24 (anti-
Thy1) antibody (black bar) or isotype control (open bar) and
infected i.d. in the ear pinnae with WR VACV. Ear pinnae and
spleen were harvested at 7 days post-infection and assayed for both
the presence of Thy1+ T cells in spleen and ear by flow cytometry,
as well as for the presence of virus by plaque assay.
(TIF)
Figure S3 Gating strategy. For all analyses, cells were gated
on a discernable scatter population that contained all CD11b+ cells
and subsequently upon cells that could be definitively identified as
singlets via the relationship of scatter area vs height or width. In
some experiments cells staining positively for a ‘‘dump’’ gate of
CD19 (B cells), CD90 (Thy1, T cells) and NK1.1 (NK cells) were
discarded from the analysis. Of the resulting cells greater than half
(on d5 post infection) typically expressed GFP in MAFIA mice and
CD11b. Data shown are representative, and are from MAFIA
mice 5d post infection with VACV.
(TIF)
Figure S4 Both Ly6C+Ly6G- and Ly6C+Ly6G+ subpopu-
lations respond to i.d. infections with viruses other than
VACV. MAFIA mice were infected i.d. in the ear pinnae with
either Herpes simplex virus (A) or adenovirus (B). Ear pinnae were
harvested 5 days post-infection and the CD11b+ GFP/CD115+
monocyte population was then analyzed for Ly6C and Ly6G
expression by flow cytometry.
(TIF)
Figure S5 Inducible nitric oxide activity does not affect
viral titer at the site of infection.Wild-type (open squares) or
Nos2-/- (filled circles) mice were infected i.d. in the ear pinnae
with WR VACV. Ear pinnae were harvested at various days post-
infection and lysates were used in a plaque assay.
(TIF)
Figure S6 Isotype control antibody to anti-Ly6G does
not increase tissue damage following VACV infection.
Mice were infected with VACV in the ear pinnae and treated with
PBS (closed circles) or isotype control (open circles) for 1A8 anti-
Ly-6G antibody (rat IgG2a) at day minus 1 and every 4 days
subsequently. Tissue loss (hole size in the ear) was measured daily.
Error bars represent S.E.M. from 10 ears. Similar to the result
shown, no significant differences were observed between lesion size
in mice treated with diluent or isotype control antibody.
(TIF)
Figure S7 Infiltration of phagocytic cells is similar in
wild-type and gp91-/- mice. Wild-type (filled diamonds) or
gp91-/- mice (open circles) were infected with VACV in the ear
pinnae. Ears were harvested, digested to produce single cell
suspensions and analyzed for the presence of CD11b+ cells (A) or
CD11b+Ly6C+Ly6G+ cells (B). Similar total numbers of cells were
obtained from each variety of mice, and numbers shown are
percentages of total cells analyzed. Error bars represent S.E.M.
from 4 ears.
(TIF)
Figure S8 Ear swelling and tissue loss is similar in
gp91-/- mice treated with depleting anti-Ly6G antibody
or isotype control. Gp91-/- mice were injected with 1A8 anti-
Ly6G (open circles) or isotype control antibody (closed squares)
24 hr prior to infection with VACV in the ear pinnae and every 4
days subsequently for the duration of the experiment. Tissue
swelling (A) and tissue damage (B) was measured at the times
shown post infection. Error bars represent S.E.M. from 10 ears.
(TIF)
Acknowledgments
We would like to thank Alexandrea MacPherson for her excellent technical
support. We also acknowledge Emmy Truckenmiller, David Tscharke,
Scott Haskett, and Brent Berwin for their discussion and feedback on this
research. We acknowledge the contribution of Nate Sheaffer of the Cell
Science/Flow Cytometry Core Facility of the Section of Research
Resources, Penn State College of Medicine.
Author Contributions
Conceived and designed the experiments: MAF MLD IER MAI GJR
CCN. Performed the experiments: MAF MLD IER CCN. Analyzed the
data: MAF MLD MAI CCN. Contributed reagents/materials/analysis
tools: MRE ELH JJS NVR CCN. Wrote the paper: MAF CCN.
The Myeloid Response to Peripheral Virus Infection
PLoS Pathogens | www.plospathogens.org 11 November 2011 | Volume 7 | Issue 11 | e1002374
References
1. Chou RC, Kim ND, Sadik CD, Seung E, Lan Y, et al. (2010) Lipid-cytokine-
chemokine cascade drives neutrophil recruitment in a murine model of
inflammatory arthritis. Immunity 33: 266–278.
2. Nathan C (2006) Neutrophils and immunity: challenges and opportunities. Nat
Rev Immunol 6: 173–182.
3. Soehnlein O, Lindbom L (2010) Phagocyte partnership during the onset and
resolution of inflammation. Nat Rev Immunol 10: 427–439.
4. Nicolas JF, Guy B (2008) Intradermal, epidermal and transcutaneous
vaccination: from immunology to clinical practice. Expert Rev Vaccines 7:
1201–1214.
5. Mitragotri S (2005) Immunization without needles. Nat Rev Immunol 5:
905–916.
6. Mikszta JA, Laurent PE (2008) Cutaneous delivery of prophylactic and
therapeutic vaccines: historical perspective and future outlook. Expert Rev
Vaccines 7: 1329–1339.
7. Tscharke DC, Reading PC, Smith GL (2002) Dermal infection with vaccinia
virus reveals roles for virus proteins not seen using other inoculation routes. J Gen
Virol 83: 1977–1986.
8. Tscharke DC, Smith GL (1999) A model for vaccinia virus pathogenesis and
immunity based on intradermal injection of mouse ear pinnae. J Gen Virol 80:
2751–2755.
9. Jacobs N, Chen RA, Gubser C, Najarro P, Smith GL (2006) Intradermal
immune response after infection with Vaccinia virus. J Gen Virol 87:
1157–1161.
10. Reading PC, Smith GL (2003) A kinetic analysis of immune mediators in the
lungs of mice infected with vaccinia virus and comparison with intradermal
infection. J Gen Virol 84: 1973–1983.
11. Xu R, Johnson AJ, Liggitt D, Bevan MJ (2004) Cellular and humoral immunity
against vaccinia virus infection of mice. J Immunol 172: 6265–6271.
12. Leon B, Lopez-Bravo M, Ardavin C (2007) Monocyte-derived dendritic cells
formed at the infection site control the induction of protective T helper 1
responses against Leishmania. Immunity 26: 519–531.
13. Dunay IR, Damatta RA, Fux B, Presti R, Greco S, et al. (2008) Gr1(+)
Inflammatory Monocytes Are Required for Mucosal Resistance to the Pathogen
Toxoplasma gondii. Immunity 29: 306–317.
14. Getts DR, Terry RL, Getts MT, Muller M, Rana S, et al. (2008) Ly6c+
"inflammatory monocytes" are microglial precursors recruited in a pathogenic
manner in West Nile virus encephalitis. J Exp Med 205: 2319–2337.
15. Wojtasiak M, Pickett DL, Tate MD, Bedoui S, Job ER, et al. (2010) Gr-1(+) cells,
but not neutrophils, limit virus replication and lesion development following
flank infection of mice with herpes simplex virus type-1. Virology 407: 143–151.
16. Wojtasiak M, Pickett DL, Tate MD, Londrigan SL, Bedoui S, et al. (2010)
Depletion of Gr-1+, but not Ly6G+, immune cells exacerbates virus replication
and disease in an intranasal model of herpes simplex virus type 1 infection. J Gen
Virol 91: 2158–2166.
17. Rivera R, Hutchens M, Luker KE, Sonstein J, Curtis JL, et al. (2007) Murine
alveolar macrophages limit replication of vaccinia virus. Virology 363: 48–58.
18. O’Gorman WE, Sampath P, Simonds EF, Sikorski R, O’Malley M, et al. (2010)
Alternate mechanisms of initial pattern recognition drive differential immune
responses to related poxviruses. Cell Host Microbe 8: 174–185.
19. Barbalat R, Lau L, Locksley RM, Barton GM (2009) Toll-like receptor 2 on
inflammatory monocytes induces type I interferon in response to viral but not
bacterial ligands. Nat Immunol 10: 1200–1207.
20. van Rooijen N, Sanders A (1994) Liposome mediated depletion of macrophages:
mechanism of action, preparation of liposomes and applications. J Immunol
Methods 174: 83–93.
21. Burnett SH, Kershen EJ, Zhang J, Zeng L, Straley SC, et al. (2004) Conditional
macrophage ablation in transgenic mice expressing a Fas-based suicide gene.
J Leukoc Biol 75: 612–623.
22. Jutila MA, Kroese FG, Jutila KL, Stall AM, Fiering S, et al. (1988) Ly-6C is a
monocyte/macrophage and endothelial cell differentiation antigen regulated by
interferon-gamma. Eur J Immunol 18: 1819–1826.
23. Hatakeyama S, Iwabuchi K, Ogasawara K, Good RA, Onoe K (1994) The
murine c-fgr gene product associated with Ly6C and p70 integral membrane
protein is expressed in cells of a monocyte/macrophage lineage. Proc Natl Acad
Sci U S A 91: 3458–3462.
24. Fleming TJ, Fleming ML, Malek TR (1993) Selective expression of Ly-6G on
myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-
differentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol
151: 2399–2408.
25. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE (2008) Use of
Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol
83: 64–70.
26. Geissmann F, Jung S, Littman DR (2003) Blood monocytes consist of two
principal subsets with distinct migratory properties. Immunity 19: 71–82.
27. Tacke F, Ginhoux F, Jakubzick C, van Rooijen N, Merad M, et al. (2006)
Immature monocytes acquire antigens from other cells in the bone marrow and
present them to T cells after maturing in the periphery. J Exp Med 203:
583–597.
28. Ruby J, Bluethmann H, Peschon JJ (1997) Antiviral activity of tumor necrosis
factor (TNF) is mediated via p55 and p75 TNF receptors. J Exp Med 186:
1591–1596.
29. Harris N, Buller RM, Karupiah G (1995) Gamma interferon-induced, nitric
oxide-mediated inhibition of vaccinia virus replication. J Virol 69: 910–915.
30. Karupiah G, Harris N (1995) Inhibition of viral replication by nitric oxide and
its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites. J Exp Med
181: 2171–2179.
31. Deonarain R, Alcami A, Alexiou M, Dallman MJ, Gewert DR, et al. (2000)
Impaired antiviral response and alpha/beta interferon induction in mice lacking
beta interferon. J Virol 74: 3404–3409.
32. van den Broek MF, Muller U, Huang S, Zinkernagel RM, Aguet M (1995)
Immune defence in mice lacking type I and/or type II interferon receptors.
Immunol Rev 148: 5–18.
33. Pollock JD, Williams DA, Gifford MA, Li LL, Du X, et al. (1995) Mouse model
of X-linked chronic granulomatous disease, an inherited defect in phagocyte
superoxide production. Nat Genet 9: 202–209.
34. Facchetti F, Vermi W, Mason D, Colonna M (2003) The plasmacytoid
monocyte/interferon producing cells. Virchows Arch 443: 703–717.
35. McLachlan JB, Catron DM, Moon JJ, Jenkins MK (2009) Dendritic cell antigen
presentation drives simultaneous cytokine production by effector and regulatory
T cells in inflamed skin. Immunity 30: 277–288.
36. Damaso CR, Esposito JJ, Condit RC, Moussatche N (2000) An emergent
poxvirus from humans and cattle in Rio de Janeiro State: Cantagalo virus may
derive from Brazilian smallpox vaccine. Virology 277: 439–449.
37. Sen CK (2009) Wound healing essentials: let there be oxygen. Wound Repair
Regen 17: 1–18.
38. Sen CK, Roy S (2008) Redox signals in wound healing. Biochim Biophys Acta
1780: 1348–1361.
39. Blanchard TG, Yu F, Hsieh CL, Redline RW (2003) Severe inflammation and
reduced bacteria load in murine helicobacter infection caused by lack of
phagocyte oxidase activity. J Infect Dis 187: 1609–1615.
40. Komatsu J, Koyama H, Maeda N, Aratani Y (2006) Earlier onset of neutrophil-
mediated inflammation in the ultraviolet-exposed skin of mice deficient in
myeloperoxidase and NADPH oxidase. Inflamm Res 55: 200–206.
41. Snelgrove RJ, Edwards L, Rae AJ, Hussell T (2006) An absence of reactive
oxygen species improves the resolution of lung influenza infection. Eur J Immunol
36: 1364–1373.
42. Zhang WJ, Wei H, Frei B (2009) Genetic deficiency of NADPH oxidase does not
diminish, but rather enhances, LPS-induced acute inflammatory responses in
vivo. Free Radic Biol Med 46: 791–798.
43. Wright GJ, Cherwinski H, Foster-Cuevas M, Brooke G, Puklavec MJ, et al.
(2003) Characterization of the CD200 receptor family in mice and humans and
their interactions with CD200. J Immunol 171: 3034–3046.
44. Schaer CA, Schoedon G, Imhof A, Kurrer MO, Schaer DJ (2006) Constitutive
endocytosis of CD163 mediates hemoglobin-heme uptake and determines the
noninflammatory and protective transcriptional response of macrophages to
hemoglobin. Circ Res 99: 943–950.
45. Poss KD, Tonegawa S (1997) Reduced stress defense in heme oxygenase 1-
deficient cells. Proc Natl Acad Sci U S A 94: 10925–10930.
46. Minamino T, Christou H, Hsieh CM, Liu Y, Dhawan V, et al. (2001) Targeted
expression of heme oxygenase-1 prevents the pulmonary inflammatory and
vascular responses to hypoxia. Proc Natl Acad Sci U S A 98: 8798–8803.
47. Otterbein LE, Lee PJ, Chin BY, Petrache I, Camhi SL, et al. (1999) Protective
effects of heme oxygenase-1 in acute lung injury. Chest 116: 61S–63S.
48. Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, et al. (2001) Cardiac-
specific expression of heme oxygenase-1 protects against ischemia and
reperfusion injury in transgenic mice. Circ Res 89: 168–173.
49. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, et al. (2002) Recruitment of
stem and progenitor cells from the bone marrow niche requires MMP-9
mediated release of kit-ligand. Cell 109: 625–637.
50. Junt T, Moseman EA, Iannacone M, Massberg S, Lang PA, et al. (2007)
Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and
present them to antiviral B cells. Nature 450: 110–114.
51. Iannacone M, Moseman EA, Tonti E, Bosurgi L, Junt T, et al. (2010)
Subcapsular sinus macrophages prevent CNS invasion on peripheral infection
with a neurotropic virus. Nature 465: 1079–1083.
52. Norbury CC, Malide D, Gibbs JS, Bennink JR, Yewdell JW (2002) Visualizing
priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat
Immunol 3: 265–271.
53. Reading PC, Moore JB, Smith GL (2003) Steroid hormone synthesis by vaccinia
virus suppresses the inflammatory response to infection. J Exp Med 197:
1269–1278.
54. Varga G, Ehrchen J, Tsianakas A, Tenbrock K, Rattenholl A, et al. (2008)
Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice
that resembles myeloid-derived suppressor cells. J Leukoc Biol 84: 644–650.
55. Jaffe ML, Arai H, Nabel GJ (1996) Mechanisms of tumor-induced immuno-
suppression: evidence for contact-dependent T cell suppression by monocytes.
Mol Med 2: 692–701.
The Myeloid Response to Peripheral Virus Infection
PLoS Pathogens | www.plospathogens.org 12 November 2011 | Volume 7 | Issue 11 | e1002374
56. Kusmartsev SA, Li Y, Chen SH (2000) Gr-1+ myeloid cells derived from tumor-
bearing mice inhibit primary T cell activation induced through CD3/CD28
costimulation. J Immunol 165: 779–785.
57. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI (2008) Subsets of myeloid-
derived suppressor cells in tumor-bearing mice. J Immunol 181: 5791–5802.
58. Corzo CA, Cotter MJ, Cheng P, Cheng F, Kusmartsev S, et al. (2009)
Mechanism regulating reactive oxygen species in tumor-induced myeloid-
derived suppressor cells. J Immunol 182: 5693–5701.
59. Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI (2004) Antigen-specific
inhibition of CD8+ T cell response by immature myeloid cells in cancer is
mediated by reactive oxygen species. J Immunol 172: 989–999.
60. Geissmann F, Gordon S, Hume DA, Mowat AM, Randolph GJ (2010)
Unravelling mononuclear phagocyte heterogeneity. Nat Rev Immunol 10:
453–460.
61. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, et al. (1995)
Altered responses to bacterial infection and endotoxic shock in mice lacking
inducible nitric oxide synthase. Cell 81: 641–650.
62. Galeazzi F, Haapala EM, van Rooijen N, Vallance BA, Collins SM (2000)
Inflammation-induced impairment of enteric nerve function in nematode-
infected mice is macrophage dependent. Am J Physiol Gastrointest Liver Physiol
278: G259–265.
63. Rosen H, Gordon S (1987) Monoclonal antibody to the murine type 3
complement receptor inhibits adhesion of myelomonocytic cells in vitro and
inflammatory cell recruitment in vivo. J Exp Med 166: 1685–1701.
The Myeloid Response to Peripheral Virus Infection
PLoS Pathogens | www.plospathogens.org 13 November 2011 | Volume 7 | Issue 11 | e1002374
